Taffic Tablet Bictegravir emtricitabine tenofovir

Taffic Tablet – Bictegravir 50 mg Emtricitabine 200mg Tenofovir Alafenamide 25 mg Description:

Taffic Tablet (bictegravir emtricitabine tenofovir) is a combination medication used for the treatment of human immunodeficiency virus (HIV) infection. It contains three active ingredients: bictegravir 50 mg emtricitabine tenofovir alafenamida. Here is some information about the uses, dosage, storage, side effects, precautions, warnings, medicine interactions, FAQs, other information, and references related to this medication:

Uses:

Tab taffic is used as part of a combination antiretroviral therapy regimen for treatment of HIV-1 in adults who have no prior antiretroviral treatment history or to replace their current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and no known substitutions associated with resistance to individual components of this medication.

Dosage:

• Take 1 tablet orally once daily with or without food.
• The tablet should be swallowed whole and not crushed, chewed, or broken.

Storage :

• Tab taffic should be stored at room temperature, away from moisture and heat.
• Keep the medication in its original container, tightly closed, and out of reach of children.

Side Effects:

• Common side effects may include diarrhea, nausea, headache, fatigue, and abdominal pain.
• Serious side effects may include changes in liver function, kidney function, bone mineral density, and lactic acidosis (a buildup of lactic acid in the blood).
• Contact your healthcare provider immediately if you experience any severe or persistent side effects while taking this medication.

Precautions and Warnings :

Use it cautiously if you have a history of kidney or liver disease. Regularly monitor liver function, kidney function, and bone mineral density while taking this medication. Do not use this medication during pregnancy, as it may harm the unborn baby. Use effective contraception during treatment and for a period after discontinuation.

Discuss with your healthcare provider if you are pregnant or planning to become pregnant. This medication may pass into breast milk, so do not breastfeed while taking it. Do not use it in children under 12 years old.